Awake extracorporeal membrane oxygenation (ECMO) as bridge to recovery after left main coronary artery occlusion: a promising concept of haemodynamic support in cardiogenic shock.

Cardiogenic shock following acute myocardial infarction is associated with high mortality rate. Different management concepts including fluid management, inotropic support, intra aortic balloon counterpulsation (IABP) and extracorporeal membrane oxygenation (ECMO) mainly in mechanically ventilated patients have been used as cornerstones of management. However, success rates have been disappointing. Few reports suggested that ECMO when performed under circumvention of mechanical ventilation, may offer some survival benefits. We herein present our experience with the use of veno-arterial ECMO as bridge to recovery in an awake and spontaneously breathing patient after left main coronary artery occlusion complicated by cardiogenic shock.

Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study.

INTRODUCTION: Neutrophil granulocytes are the first defense line in bacterial infections. However, granulocytes are also responsible for severe local tissue impairment. In order to use donor granulocytes, but at the same time to avoid local side effects, we developed an extracorporeal immune support system. This first-in-man study investigated whether an extracorporeal plasma treatment with a granulocyte bioreactor is tolerable in patients with septic shock. A further intention was to find suitable efficacy end-points for subsequent controlled trials. METHODS: The trial was conducted as a prospective uncontrolled clinical phase I/II study with 28-day follow-up at three university hospital intensive care units. Ten consecutive patients (five men, five women, mean age 60.3 ± 13.9 standard deviation (SD) years) with septic shock with mean ICU entrance scores of Acute Physiology and Chronic Health Evaluation (APACHE) II of 29.9 ± 7.2 and of Simplified Acute Physiology Score (SAPS) II of 66.2 ± 19.5 were treated twice within 72 hours for a mean of 342 ± 64 minutes/treatment with an extracorporeal bioreactor containing 1.41 ± 0.43 × 10E10 granulocytes from healthy donors. On average, 9.8 ± 2.3 liters separated plasma were treated by the therapeutic donor cells. Patients were followed up for 28 days. RESULTS: Tolerance and technical safety during treatment, single organ functions pre/post treatment, and hospital survival were monitored. The extracorporeal treatments were well tolerated. During the treatments, the bacterial endotoxin concentration showed significant reduction. Furthermore, noradrenaline dosage could be significantly reduced while mean arterial pressure was stable. Also, C-reactive protein, procalcitonin, and human leukocyte antigen DR (HLA-DR) showed significant improvement. Four patients died in the hospital on days 6, 9, 18 and 40. Six patients could be discharged. CONCLUSIONS: The extracorporeal treatment with donor granulocytes appeared to be well tolerated and showed promising efficacy results, encouraging further studies. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00818597.

A novel visually CO2 controlled alveolar breath sampling technique.

BACKGROUND: A crucial issue in the analysis of exhaled breath is the collection of gaseous samples. The analysis of pure alveolar gas is the method of choice if contamination of samples is to be minimized. Monitoring of expired CO2 can be used to identify alveolar gas. The purpose of this study was to evaluate a bed side version of this technique using visual CO2 control by means of a capnometer. METHODS: 22 mechanically ventilated patients of an ICU were enrolled into the study. Alveolar and mixed expiratory gas, and arterial blood were sampled. PCO2 in blood and gas was determined in a blood gas analyzer. End tidal PCO2 was monitored in all patients by a fast responding main stream capnometry. Taking the gaseous samples was visually synchronized with the expired CO2. RESULTS: Alveolar CO2 contents measured during two different respiratory cycles were identical (p 0.86). The variation of the CO2 content during 10 measurements in one patient was lower than 4%. Arterial PCO2, PCO2 in alveolar gas and end tidal PCO2 showed positive correlation. CONCLUSIONS: The visually CO2-controlled sampling technique of alveolar gas is a reliable and reproducible method. It represents an important step in simplifying and standardizing breath analysis.

[Not Available]. / Primäre Stentversorgung eines thrombotisch verschlossenen Hauptstammes im kardiogenen Schock.

Acute left main coronary artery (LMCA) occlusion is associated with a high mortality rate. The majority of patients with this clinical condition die suddenly or from cardiogenic shock. We report a case of cardiogenic shock resulting from acute main coronary occlusion. Emergency cardiac catheterization was performed and coronary angiography showed a totally occluded LMCA. Prompt revascularization by means of primary LMCA stenting was successful and the patient was discharged 16 days later without neurological deficit or clinical signs of heart failure. We suggest that the rapid coronary angiography followed by angioplasty and primary stent implantation was instrumental in saving this patient's life.